
Expert Systems, Inc. is a global target to clinic accelerator that combines human and artificial intelligence to accelerate drug discovery. Their comprehensive hybrid AI/ML platform covers all aspects of preclinical drug discovery, including target identification, virtual screening, and pharmacokinetics. By leveraging proprietary and public databases, they provide competitive intelligence to de-risk candidate selection, facilitating a fast transition from in silico to first-time-in-man. The company also sets up seed and series A companies and manages R&D programs for investors and strategic partners across North America, Europe, and Australia.

Expert Systems, Inc. is a global target to clinic accelerator that combines human and artificial intelligence to accelerate drug discovery. Their comprehensive hybrid AI/ML platform covers all aspects of preclinical drug discovery, including target identification, virtual screening, and pharmacokinetics. By leveraging proprietary and public databases, they provide competitive intelligence to de-risk candidate selection, facilitating a fast transition from in silico to first-time-in-man. The company also sets up seed and series A companies and manages R&D programs for investors and strategic partners across North America, Europe, and Australia.